Transcription factor GATA4 is required for the development and function of the mammalian gonads. We first reported that the GATA4 gene in both human and rodents is expressed as two major alternative transcripts that differ solely in their first untranslated exon (exon 1a vs. exon 1b). We had also showed by quantitative PCR that in mouse tissues, both Gata4 exon 1a-and 1b-containing transcripts are present in all sites that are normally positive for GATA4 protein. In adult tissues, exon 1a-containing transcripts generally predominate. A notable exception, however, is the testis where the Gata4 exon 1a and 1b transcripts exhibit a similar level of expression. We now confirm by in situ hybridization analysis that each transcript is also strongly expressed during gonad differentiation in both sexes in the rat. To gain further insights into how Gata4 gene expression is controlled, we characterized the mouse Gata4 promoter sequence located upstream of exon 1b. In vitro studies revealed that the Gata4 1b promoter is less active than the 1a promoter in several gonadal cell lines tested. Whereas we have previously shown that endogenous Gata4 transcription driven by the 1a promoter is dependent on a proximally located Ebox motif, we now show using complementary in vitro and in vivo approaches that Gata4 promoter 1b-directed expression is regulated by GATA4 itself. Thus, Gata4 transcription in the gonads and other tissues is ensured by distinct promoters that are regulated differentially and independently.
INTRODUCTION
Transcription factor GATA4 is a key regulator required for the development and function of the mammalian gonads. GATA4 protein is a marker of the somatic cell lineages of the male and female gonads. It is found starting in the somatic cell precursors of the urogenital ridges and then in Sertoli, Leydig, and peritubular cells of the testis and in granulosa, theca, and luteal cells of the ovary [1-5; reviewed in 6, 7] . In the seminiferous tubules of adult testis, Gata4 expression in Sertoli cells is independent of the stage of germ cell maturation [1] . In contrast, Gata4 in the ovary is expressed in potentially mitotic and proliferating granulosa cells, and expression is downregulated when proliferation ceases during ovulation, apoptosis, or luteinization [8, 9] . GATA4 has also been reported in Sertoli and Leydig cell tumors as well as ovarian granulosa and surface epithelium cell tumors [10, 11] . The transcriptional activities of the GATA proteins are modulated by their interactions with other transcription factors and with transcriptional coactivators and repressors. ZFPM2 (also known as FOG2, Friend of GATA-2) is a multi-zinc-finger protein that is coexpressed with GATA4 in a number of sites and modulates positively or negatively the activity of GATA family proteins by physically interacting with the N-terminal zinc finger of GATA4 [12] . Zfpm2/Fog2 is expressed in the gonad from the fetal urogenital ridge stage to adulthood [3, 4, 9, 12, 13] .
The ever-expanding list of GATA4 target genes illustrates the pivotal role of this factor in the molecular cascade of events leading to organogenesis during fetal development [reviewed in 6, 7] . In the gonads, the Sry, Sox9, and Dmrt1 genes are important early targets [14] [15] [16] , while later in life, the regulation of steroidogenic genes appears to be an important function for GATA4 [6, [17] [18] [19] [20] [21] [22] [23] . Because of the early embryonic lethality due to misclosure of the ventral wall of the animal that affects both heart and gut morphogenesis [24, 25] , the in vivo demonstration of a role for GATA4 in gonad differentiation and function has come from several novel transgenic mice studies that either expressed a mutant form of GATA4 that had an impaired ability to interact with FOG2 (Gata4 ki ), generated a gonad-specific knockout of Gata4 or Fog2, or conditionally overexpressed Gata4 small interfering RNA in the gonads [14, 16, 21, 22, [26] [27] [28] . The crucial role for GATA4 in gonadal development and function is now being slowly extended to humans with the identification of mutations or small deletions impairing GATA4 function that are associated with anomalies of testis development [29, 30] .
Because of their broad action in organs, GATA factors have been long considered as tissue-specific housekeeping genes [reviewed in 31] . Indeed, the GATA family of genes share common features that include the use of several variably distant enhancers as well as several variably distant 5 0 -untranslated exons, which are under the control of distinct promoter units [32-38; reviewed in 39, 40] . On the one hand, tissue specificity of Gata4 expression is likely achieved by several enhancers such those described for gut, liver, and heart [41] [42] [43] [44] . On the other hand, we previously reported alternative 5
0 -untranslated first exon usage for Gata4 and found that in mouse, rat, and human, the GATA4 gene is expressed as several transcripts that differ in their first exon [38] . Of these, only two are conserved between species: Gata4 exon 1a (E1a, which is located most proximal to the GATA4 ATG) and a distant one named Gata4 E1b. While the tissue specificity of Gata4 1b promoter activity has yet to be described, 5 kb of regulatory sequences upstream of E1a allow the expression of a GFP reporter gene in Sertoli cells of the testis throughout ontogeny [45, 46] . We and others have previously described the regulation of the mouse Gata4 1a promoter in vitro and in vivo by ubiquitous factors such as USF1, USF2, and SP1 [38, [47] [48] [49] . Unlike the Gata4 1a promoter, the mechanisms that control the activity of the distal Gata4 1b promoter remain unknown. Therefore, we characterized the mouse Gata4 promoter sequence located upstream of E1b and showed that its activity is autoregulated by GATA4 itself. This novel finding therefore represents a potentially key mechanism for regulating Gata4 expression in different cell types and at different time points during development in the gonads and possibly other Gata4-expressing tissues.
MATERIALS AND METHODS

Animal Handling, Tissue Collection, and Processing
Adult Sprague-Dawley rats (Janvier) were housed under standard conditions, fed a standard rodent chow, provided with tap water, maintained on a 12L:12D cycle, and monitored for specific pathogens according to the Federation for Laboratory Animal Science Associations (FELASA) recommendations. All the procedures involving animals were conducted in accordance with institutional guidelines and in compliance with national and international laws and policies (Council Directive no. 87-848 of 19 October, 1987 , French Ministry of Agriculture and Forestry). Pregnant females were euthanized by CO 2 inhalation. Noon on the day following mating was designated as Embryonic Day 0.5 (e0.5). For immunohistochemical analyses and in situ hybridizations, gonads were fixed in 4% paraformaldehyde-PBS, pH 7.2, for 1 h at 48C, cryoprotected in 20% sucrose in PBS, embedded in TissueTek optimal cutting temperature compound (Miles, Inc.), cut into 8 lm-thick sections, and mounted onto 3-aminopropyltriethoxysilane (Sigma-Aldrich Canada)-treated glass slides and stored at À208C. Mice harboring a gonadspecific inactivation of Gata4 (Gata4 À/À ) were obtained by crossing an Nr5a1-Cre line with Gata4 flox/flox mice as previously described [14] . All the animal work involved in the generation of the gonad-specific Gata4 null tissues was approved by the Institutional Animal Care and Use Committees of Dartmouth College and the University of Florida.
RNA Extraction from Mouse Testis and Quantitative RealTime PCR
Testes and ovaries were dissected from the control and mutant fetuses at e14.5 as previously described [14] . At this developmental time point, GATA4 is the predominant GATA factor present in these tissues. Total RNA was isolated from tissues using Trizol reagent (Invitrogen) in accordance with the manufacturer's protocol except that tissues were homogenized in 0.5 ml of Trizol reagent and the amounts of chloroform and isopropyl alcohol used in the extractions were halved. First-strand cDNAs were synthesized from 0.16 to 0.75 lg aliquot of RNA using SuperScript III Reverse Transcriptase (Invitrogen). Quantitative real-time PCR was performed using the LightCycler FastStart DNA Master SYBR Green I kit (Roche Diagnostics Canada) according to the manufacturer's instructions. DNA fragments containing E1a and E1b of the mouse Gata4 gene were amplified by PCR and cloned into pGEM-T easy vector (Promega). In each run, serial DNA plasmid dilutions were prepared for the standard curves, and differences in mRNA levels between samples were quantified from the latter. As an internal control, quantitative real-time PCRs (qPCRs) were performed using the cloned fragment of the housekeeping ribosomal Rpl19 gene as reference. Each sample was analyzed in duplicate using the primers shown in Table 1 . All the qPCR runs were done using the following conditions: 10 min at 958C followed by 40 cycles of denaturation (5 sec at 958C), annealing (5 sec at 608C), and amplification (20 sec at 728C) with single acquisition of fluorescence levels at the end of each cycle. PCR products were analyzed with the melting curve and agarose gel electrophoresis to confirm the specificity of the amplified fragment. Data are reported as a percentage of the respective wild-type (WT; i.e., control) testis or ovary from a minimum of four independent samples.
Conventional PCR
Conventional PCR was done using a Mastercycler gradient thermocycler (Eppendorf Scientific) using Vent polymerase (New England Biolabs) and the following conditions: 3 min at 958C followed by 30 cycles of denaturation (30 sec at 958C), annealing (30 sec at 608C), and extension (30 sec at 728C) with a final extension step of 5 min at 728C. PCR products were then analyzed by agarose gel electrophoresis, stained with ethidium bromide, and visualized by fluorescence with an AlphaImager system (Alpha Innotech Corporation). Primers used for each amplification are presented in Table 1 . Each amplification was performed three times using three different preparations of first-strand cDNAs resulting from three different RNA extractions.
In Situ Hybridization and Immunofluorescence
Specific rat Gata4 E1a and E1b cDNAs were generated with primers described in Table 1 and cloned into pGEM-T easy vector (Promega). Digoxigenin-labeled riboprobes were generated by in vitro transcription. In situ hybridization on frozen tissue sections was carried out as previously described [50] . For anti-Mü llerian hormone (AMH) immunofluorescence labeling following in situ hybridization, sections were boiled for 5 min in 0.1 M citrate buffer, pH 6.0, for antigen retrieval, blocked with 10% horse serum (in PBS with 8% bovine serum albumin [BSA] ) for at least 20 min, and finally incubated overnight at 48C with primary antibody directed against AMH (MCA2246T; AbD Serotec) diluted 1:100 in Dako antibody diluent (Dako Cytomation). After washing in PBS, sections were incubated for 1 h with a 1:500 dilution of Alexa-488 anti-mouse antibody (Invitrogen). Sections were mounted with Vectashield mounting medium (Vector Laboratories). Slides were analyzed with a Zeiss Akioskop II epifluorescence microscope (Carl Zeiss Canada Ltd.) connected to a digital camera (Carl Zeiss).
Plasmids
The 2000 bp and the 171 bp Gata4 1b promoter fragments (À2000 to þ81 bp, and À171 to þ81 bp, respectively) were obtained by PCR using genomic DNA as template and the primer pairs described in Table 1 . The amplified products were subcloned into the BamHI/Bgl II sites of a modified pXP1 luciferase reporter vector [51] . The plasmids containing deletions of promoter 1a (À2100 to þ85 and À118 to þ85 bp) have been previously described [45] . Gata4 promoter 1b constructs containing mutations in specific regulatory motifs were obtained by site-directed mutagenesis of the parent À171 bp construct using a QuikChange XL mutagenesis kit (Stratagene) and the primer pairs listed in Table 1 . All the cloned promoter sequences, deletions, and mutations were confirmed by sequencing. The WT GATA4 and E215K expression plasmids were previously described [13, 51] 
Cell Culture and Transfection Assays
Mouse MSC-1 (Sertoli; provided by Dr. Michael Griswold, Washington State University), rat DC3 (granulosa; provided by Dr. Riaz Farookhi, McGill University), and human HeLa (epithelial carcinoma; ATCC) cell lines were maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum. Monkey CV-1 (fibroblast; ATCC) cells were grown in DMEM containing 10% newborn calf serum. Mouse MA-10 (Leydig; provided by Dr. Mario Ascoli, University of Iowa) cells were cultured in Waymouth MB752/1 medium (Sigma-Aldrich Canada) supplemented with 20 mM HEPES and 15% horse serum. Mouse TM3 (Leydig; ATCC) and TM4 (Sertoli; ATCC) cells were grown in DMEM/F12 containing 2.5% fetal bovine serum and 5% horse serum, and 10% fetal bovine serum, respectively. All the cells were grown at 378C and 5% CO 2 . Cell transfections were performed in 24-well plates using the calcium phosphate precipitation method, and luciferase activity was measured as previously described [52] . For comparison of Gata4 1a and 1b promoter activities in different cell lines, phRL-TK Renilla luciferase vector (20 ng/well) was used as the internal control along with the Dual Luciferase Reporter Assay System from Promega. For all the experiments, the data reported represent the average of at least three experiments, each done in duplicate.
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DNA Binding Assay
To assess binding of GATA4 to the consensus GATA sites in the mouse Gata4 1b promoter, MA-10 cell nuclear extracts (which contain abundant GATA4 protein) were prepared by the procedure outlined by Schreiber et al. [53] . Electrophoretic mobility shift assays (EMSA) were performed using a 32 P-labeled double-stranded oligonucleotide corresponding to the proximal GATA element (GATA site 1) and to the more distal GATA motif (GATA site 2) of the mouse Gata4 1b promoter. Competition experiments with unlabeled oligonucleotides corresponding to WT and mutated (Mut; i.e., GATA to GGTA) GATA motifs were used to confirm the specificity of GATA4 binding. Oligonucleotides used in the EMSA assays are presented in Table 1 . Binding reactions were prepared that contained 5 lg nuclear extract, 50 000 cpm radiolabeled probe, 1 lg of poly (dI:dC), 100 ng BSA and binding buffer (4 mM Tris-HCl, pH 8.0, 24 mM KCl, 0.4 mM dithiothreitol, 0.4 mM ethylenediaminetetraacetic acid [EDTA], pH 8.0, 5 mM MgCl 2 , and 10% glycerol), then incubated for 1 h on ice. For supershift assays, 1.5 lg of goat polyclonal anti-GATA4 antibody (Santa Cruz Biotechnology) was added to the reaction to confirm GATA4 as the predominant GATA protein present in the MA-10 extract. Normal goat or rabbit immunoglobulin G (IgG) was used as controls (data not shown). The reactions were loaded on a 4% polyacrylamide gel that had been preelectrophoresed at 200 V for 1 h at 4 C. Electrophoresis of the samples was continued for 60-90 min, dried for 30-45 min, and exposed to film (Kodak BioMax MS; Carestream Health Inc.).
Chromatin Immunoprecipitation
MA-10 cells were seeded in 60 mm Petri dishes, and after 48 h of culture, the cells were cross-linked with 1% formaldehyde for 10 min at 37 C, washed with cold PBS, and then scraped. Cell pellets were washed for 10 min at 4 C, each time with 1 ml cold buffer I (0.25% Triton X-100, 10 mM EDTA, 0.5 mM ethylene glycol tetraacetic acid, 10 mM HEPES pH 6.5) and 1 ml cold buffer II (200 mM NaCl, 1 mM EDTA, 0.5 mM ethylene glycol tetraacetic acid, 10 mM HEPES pH 6.5). Pellets were then suspended in 200 ll sonication buffer (1% SDS, 10 mM EDTA, 50 mM Tris, pH 8.0) containing the freshly added protease inhibitors aprotinin, leupeptin, pepstatin, and phenylmethylsulfonyl fluoride (Sigma-Aldrich Canada). Pellets were left on ice for 10 min before sonicating with a Misonix S-4000 3-in cup horn sonicator (Qsonica) 100 times for 20 sec on and 20 sec off at 80% power. Extracts were then centrifuged at 48C for 10 min at 13 000 rpm and the supernatants collected (10% was kept for input). DNA fragments between 1 and 0.1 kb in length were obtained and visualized on an agarose gel after reverse cross-linking and purification. Prior to immunoprecipitation, a dynabead/antibody complex was prepared (for each reaction) by first taking a 40 ll aliquot of dynabead protein G (Life Technologies Inc.) and washing it twice with 500 ll of PBS plus 0.5% BSA.
Following the washes, 500 ll of PBS plus 0.5% BSA was added to the beads, followed by 5 lg of GATA4 antibody (sc-1237x; Santa Cruz Biotechnology) or control goat IgG (20011-250; Alpha Diagnostic International) and incubated overnight at 48C on a rotating wheel. The next day, the bead-antibody complexes were washed twice with 500 ll of PBS plus 0.5% BSA, resuspended in 100 ll PBS plus 0.5% BSA, and added to 180 ll of sonicated extract and 1620 ll dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 167 mM NaCl, 16.7 mM Tris-HCl, pH 8.0, and freshly added protease inhibitors). The reaction was incubated for 4 h at 48C on a rotating wheel. Afterwards, the beads were washed four times with 1 ml chromatin immunoprecipitation (ChIP) wash buffer (100 mM Tris, pH 7.4, 500 mM LiCl, 1% sodium deoxycholate, 1% Igepal) for 5 min at 48C on a rotating wheel. Beads underwent a final wash with 1 ml of 10 mM Tris, pH 8, plus 1 mM EDTA before elution (two times) with 200 ll of freshly prepared elution buffer (1% SDS, 0.1M NaHCO 3 ) for 15 min at room temperature with shaking on a vortex. The two eluates were pooled together (400 ll), 16 ll of 5M NaCl was added, and the solution was reverse cross-linked overnight at 65 C. The reverse cross-linked solution was then treated with 2 ll of 10 mg/ml proteinase K (Bioshop Canada), 5 ll of 0.5 M EDTA, and 16 ll of 1 M Tris-HCl, pH 6.5. DNA was isolated with a MinElute PCR purification kit (Qiagen) and eluted into 40 ll of 10 mM Tris-HCl, pH 8.5. Quantitative PCR reactions were performed using 2 ll of the ChIP DNA and 2 ll of the input diluted 10-fold. The mouse Gata4 1b proximal promoter region containing the GATA4 regulatory motifs (À138 to À37 bp) as well as an unrelated distal Gata4 1b promoter region not containing GATA motifs (À3139 to À3002 bp) were amplified by qPCR using the primer pairs indicated in Table  1 . The qPCR reactions were performed with the following conditions: 10 min at 958C followed by 40 cycles of denaturation (5 sec at 958C), annealing (5 sec at 628C), and extension (20 sec at 728C). PCR products were confirmed by their melting curve and sequencing. The DDCt method was used to quantitate relative differences between treatment groups, and the input DNA Ct value was used to normalize the ChIP data. A Mann-Whitney rank sum test was used to identify significant differences between samples.
Statistical Analyses
To identify significant differences between multiple groups, statistical analyses were done using either a one-way analysis of variance followed by a Holm-Sidak post hoc test or a nonparametric Kruskal-Wallis one-way analysis of variance followed by Newman-Keuls tests when conditions of normality and/or equal variance between groups was not met. Single comparisons between two experimental groups were done using either a paired Student t-test or again a Mann-Whitney U-test when conditions of normality/variance failed. For all the statistical analyses, P , 0.05 was considered significant. All the statistical analyses were done using the SigmaStat software package (Systat Software Inc.). GATA4 GENE AUTOREGULATION FIG. 1. In vivo distribution of E1a-and E1b-containing Gata4 mRNA. In situ hybridization of Gata4 mRNA corresponding to either the whole Gata4-coding sequence spanning E2 to E7 (E2-E7), to E1a-containing Gata4 mRNA linked to a shortened or full E2 (E1a-E2 short, E1a-E2 long), or to E1b-containing Gata4 mRNA (E1b-E2) in rat male e13.5 embryos (A), e16.5 testes (B-E), female e13.5 embryos (F), and e16.5 ovaries (G). In situ hybridizations were done on consecutive sections. Control E1a and E1b sense probes are shown in the insets. Sertoli cells are labeled with AMH (C) after in situ hybridization for each Gata4 transcript (D) and merged pictures are shown (E). Arrows point to AMH-negative Gata4-positive Leydig cells. Bars ¼ 100 lm.
RESULTS
Expression of Gata4 Transcripts Initiating from Both 1a and 1b Noncoding Exons During Gonad Differentiation
In previous studies, the endogenous localization of the alternative Gata4 transcripts in the different cell types of the mouse gonad proved to be technically difficult [38] . We therefore reinvestigated the distribution of the different Gata4 transcripts by in situ hybridization in rat gonads. In the rat, we previously showed the expression of two isoforms of E1a: one connected to a long E2 (E1a-E2 long) and the other one to a shortened E2 (E1a-E2 short) [38] . The expression pattern of both E1a-and of E1b-specific transcripts was compared to that of a sequence shared by all the transcripts (spanning the entire GATA4 coding sequence from the ATG in E2 to the stop codon in E7; E2-E7, Fig. 1 ). In e13.5 developing testis, all Gata4 E1-specific transcripts were expressed in a similar pattern to the sequence encompassing the whole coding sequence E2-E7 (Fig. 1A) . Similarly in e16.5 testes, all E1-specific transcripts as well as the E2-E7 transcript were found in Sertoli cells inside cords as highlighted by the colabeling of Sertoli cells with AMH and in scattered cells in the mesenchyme that corresponded to fetal Leydig cells (Fig.  1B-E) . All the Gata4 E1-specific transcripts were found in a similar profile in e13.5 developing ovary and in e16.5 fetal ovarian cords (Fig. 1, F and G) . Expression profile analyses thus show that endogenous Gata4 E1-specific transcripts share a similar pattern of expression to that of the GATA4 protein in rodent fetal gonads [54] .
Gata4 1a and 1b Promoters Display Distinct Efficiencies
In order to compare the activities of the promoter regulatory sequences upstream of each E1, we first screened for possible differences in expression of the Gata4 E1-specific transcripts in several gonadal cell lines corresponding to typical cell types of the gonads and assessed for their absence in heterologous cell lines (CV-1 and HeLa) (Fig 2A) . In agreement with the in situ hybridization profiles, conventional PCR analyses revealed the coexpression of both Gata4 E1a-and E1b-containing transcripts in mouse Sertoli (MSC-1, TM4), Leydig (TM3, MA-10) and rat granulosa (DC3) cell lines.
We further investigated the activity of the regulatory sequences upstream of each mouse exon by transient transfections of luciferase reporter constructs in several Gata4-expressing and heterologous cell lines by using a series of 5 0 deletions linked to luciferase reporter gene (Fig. 2B ). When transfected in either homologous GATA4-expressing gonadal cells lines (MSC-1, TM4, TM3, DC3) or heterologous GATA4-negative cells (CV-1, HeLa), the À2100 bp Gata4 1a promoter fragment had an activity comparable to the previously reported minimal À118 bp 1a construct [45] . In contrast, the activity of the similar sized À2000 and À171 bp Gata4 1b promoters were 80% to 90% less than that of the corresponding 1a promoter sequences. While low, Gata4 1b promoter activity was well above the promoterless control, suggesting that it does contribute to Gata4 expression as evidenced by the PCR and in situ hybridization data (Figs. 1  and 2A ). Since the À171 bp 1b promoter fragment was as active as the longer À2000 bp 1b fragment, this suggested that the regulatory elements required for basal Gata4 1b promoter activity reside in the first 171 bp upstream of E1b.
GATA-Dependent Regulation of Gata4 1b Promoter Activity
Sequence analysis of the first 171 bp upstream of E1b revealed the presence of several species-conserved regulatory motifs tightly clustered between nucleotide positions À88 and À54 bp: one AP1-like motif, one WT1 element, and two perfect binding sites for GATA proteins (Fig. 3A) . The functional relevance of these conserved putative transcription factorbinding sites then was studied by complementary cotransfection, mutagenesis, and EMSA studies. As shown in Figure 3B , transfection of either WT1 (ÀKTS isoform), FOS, or JUN in heterologous CV-1 fibroblasts did not significantly activate the minimal À171 bp Gata4 1b promoter. In contrast, transfection of GATA4 by itself resulted in a 6-fold activation of the À171 bp Gata4 1b promoter. This effect was not enhanced by cotransfection of GATA4 with the other potential regulatory proteins (Fig. 3B) . The stimulatory effect of GATA4 was even reduced in the presence of WT-1 or FOS/JUN, most likely due to the known interaction between GATA4 and these factors [55] [56] [57] .
The potential GATA-dependent regulation of the Gata4 1b promoter prompted us to reexamine the possibility that a similar regulation might also exist at the level of the Gata4 1a promoter. A screen of a conserved intron region upstream of GATA4 E1a revealed a highly (98%) conserved 107 bp region located at À1 kb, which indeed contained a conserved consensus GATA-binding site (Fig. 4A) . Transfection experiments were then used to test the importance of this GATA motif for Gata4 1a promoter activity (Fig. 4, B and C) . However, deletion analysis revealed that this GATA motif was dispensable for Gata4 1a promoter activity in a variety of homologous and heterologous cell lines (Fig. 4B) . Moreover, the activity of Gata4 1a promoter constructs containing the GATA motif was not affected by overexpression of GATA4 (Fig. 4C) . These data suggest that while the Gata4 1b promoter appears to be autoregulated by GATA4 itself, this may not be the case for Gata4 1a promoter.
To further explore the functionality of the GATA motifs of the Gata4 1b promoter, we performed EMSA assays (Fig. 5A) . Using an oligonucleotide probe encompassing either the proximal or distal GATA binding sites (À83 to À78 bp and À95 to À90 bp, respectively) and protein extracts prepared from MA-10 Leydig cells, a prominent protein/DNA complex formed that could be entirely supershifted in the presence of a GATA4 antibody, indicating that GATA4 is the predominant GATA factor of MA-10 cell nuclear extracts. GATA4 binding was specific for the GATA motifs because binding was efficiently competed with the respective unlabeled probes (Fig.  5A, lanes 2, 3, 9 , and 10) but not with unlabeled probes containing a mutation in the either the proximal or distal GATA binding motifs (Fig. 5A, lanes 4, 5, 11, and 12) . We then used cotransfection experiments in heterologous CV-1 cells to show that the GATA-binding motifs of the Gata4 1b promoter are functionally active (Fig. 5B) . As shown in Figure  5B , mutation of the GATA motifs, either alone or together, resulted in a loss of GATA responsiveness of the Gata4 1b promoter. Taken together, the DNA-binding and transfection experiments support the notion that the Gata4 1b promoter is under GATA control.
Gata4 1b Promoter Activity Is Negatively Regulated by GATA4 in Gonads In Vivo
Our in vitro data suggest that the Gata4 1b promoter is positively autoregulated by GATA4. To test this hypothesis in 0 deletion analysis of the Gata4 1a and 1b promoters. The different Gata4 promoter luciferase constructs (0.5 lg/well) were transiently transfected in either homologous (MSC-1, TM4, TM3, DC3) or heterologous (CV-1, HeLa) cell lines. Promoter activities are expressed as arbitrary units relative to the À2100 bp promoter 1a construct 6 SEM. For each promoter, an asterisk indicates a significant difference between the truncated and corresponding full-length sequence (*P , 0.5; **P , 0.01; ***P , 0.001).
an in vivo context, we examined the expression levels of the Gata4 E1a and E1b transcripts by qPCR in Gata4 null gonads at e14.5 (Fig. 6 ). This fetal stage was specifically chosen because GATA4 is the predominant GATA factor present. The targeted region in Nr5a1Cre;Gata4 flox/flox males, which is sufficient to block formation of GATA4 protein [14] , is nonetheless downstream of the Gata4 E1a/E1b region and thus permits an evaluation of the expression of the Gata4 1a/1b transcripts in the absence of GATA4 protein. In both e14.5 GATA4 null testis and ovary, Gata4 E1a transcript levels were not affected by the loss of GATA4. This lack of GATA regulation at the level of the Gata4 1a promoter supports our in vitro findings (Fig. 4) . Surprisingly however, Gata4 1b transcript expression was increased in Gata4 null gonads and especially in the fetal testis where the change was found to be statistically significant (Fig. 6A ). While these data confirm the participation of GATA4 in the control of the Gata4 1b promoter as suggested by our in vitro data, the mode of FIG. 3 . Regulation of Gata4 1b promoter activity by putative transcriptional regulators. A) Alignment of the mouse, rat, and human Gata4 proximal 1b promoter sequences reveals conserved putative cis-regulatory elements (underlined sequences). Two potential binding sites for GATA, one putative binding site for AP1, and one putative binding site for WT1 are underlined. B) Cotransfection analysis of the minimal Gata4 1b promoter with putative regulators. CV-1 cells were cotransfected with the minimal Gata4 1b promoter construct (500 ng) along with an empty vector or expression vectors for GATA4 (100 ng), WT1 (ÀKTS) (500 ng), FOS (125 ng), or JUN (125 ng), used alone or in combination. Promoter activities are reported as fold activation over control 6 SEM. Different letters indicate a significant difference between groups (P , 0.05, Kruskal-Wallis ANOVA followed by Newman-Keuls tests).
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regulation in vivo appears to be one of negative autoregulation mediated by GATA4 binding. As shown in Figure 7 , ChIP analysis using MA-10 Leydig cells confirmed that GATA4 is indeed associated with the native Gata4 1b promoter. In comparison to control IgG, ChIP using a GATA4 antibody detected a significant recruitment of GATA4 to the Gata4 1b proximal promoter region containing the two GATA regulatory motifs (Fig. 7A) . Recruitment of GATA4 to the Gata4 1b proximal promoter region was also markedly greater than the recruitment observed to an unrelated distal promoter region that does not contain GATA regulatory motifs (Fig. 7B) .
As previously mentioned, the activity of the different GATA family members is strictly regulated (either positively or negatively) through interaction with other transcriptional partners and by posttranslational modification of the GATA proteins themselves [reviewed in 6, 31] . At a transcriptional level, GATA4-mediated repression has been reported to involve the participation of its cofactor FOG2, which is FIG. 4. The Gata4 1a promoter is not autoregulated by GATA4. A) Alignment of the rat, mouse, human, and dog Gata4 highly conserved module located at À1010/À845 bp from E1a reveals a conserved GATA-binding site. B) The 5 0 deletion analysis of the mouse Gata4 1a promoter. The different Gata4 promoter luciferase constructs (0.5 lg/well) were transiently transfected in either homologous (MSC-1, TM4, TM3, DC3) or heterologous (CV-1, HeLa) cell lines. Promoter activities are expressed as fold activation over the À1010 bp construct (6 SEM). C) Cotransfection analysis of the Gata4 1a promoter with GATA4. CV-1 and HeLa cells were cotransfected with several deleted Gata4 1a promoter constructs (500 ng) along with an empty vector or expression vector for GATA4 (100 ng). Promoter activities are reported as fold activation over control 6 SEM. No significant differences were observed between groups (P , 0.05, Kruskal-Wallis ANOVA followed by Newman-Keuls tests).
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mutually coexpressed with GATA4 in gonadal cells and is known to potently repress GATA4 activity on many promoters [13] . A similar mode of regulation might then exist at the level of the Gata4 1b promoter. To test this hypothesis, we examined whether exogenously added FOG2 could repress Gata4 1b promoter activity in both homologous and heterologous cell contexts (Fig. 8) . In MA-10 Leydig and MSC-1 Sertoli cells (which express abundant GATA4 protein) FOG2 alone significantly repressed Gata4 1b promoter activity (Fig. 8A) , whereas in heterologous CV-1 cells (that do not express GATA4) the inhibition was markedly attenuated and was significant only at the highest FOG2 doses. In both cell contexts, FOG2 also completely eliminated the stimulatory effect of GATA4 on the activity of the Gata4 1b promoter. To ensure that the observed repression was indeed due to the interaction between GATA4 and FOG2, we repeated the experiment using a mutated GATA4 protein (E215K) [13, 58] that does not efficiently bind FOG2 (Fig. 8B) . In contrast to the P-labeled oligonucleotide corresponding to either the proximal or distal GATA-binding site of the Gata4 1b promoter was used as the probe. The competitor oligonucleotides and supershift antibody are indicated. B) Site-directed mutagenesis was used to inactivate the GATA motifs in context of the minimal Gata4 1b promoter fragment (À171/þ81 bp). The constructs (0.5 lg/well) were transfected in the heterologous CV-1 cells. Promoter activities are expressed as fold activation over basal activity (no GATA4 present) for each construct 6 SEM. Asterisks indicate significant differences from basal activity (dotted lined). Different letters indicate significant differences between means (P , 0.05).
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À/À gonads. Real-time PCR was used to assess the level of Gata4 E1a and E1b transcripts in Gata4 À/À fetal testis (A) and ovary (B) at e14.5. Quantitative data was normalized using the housekeeping Rpl19 gene, and changes in expression reported as a percentage of the respective WT testis or ovary (controls) (6 SEM). The dotted line represents 100%, indicating no effect on transcript expression. Values above the dotted line indicate an increase in expression. An asterisk indicates a significant difference from the wild-type animal (P , 0.001, two-tailed paired t-test).
FIG. 7.
GATA4 is recruited to the proximal Gata4 1b promoter. A) MA-10 cell lysates were prepared, and chromatin was immunoprecipitated with a GATA4 antibody or with goat IgG, which served as a negative control. A DNA fragment spanning a portion of the Gata4 1b promoter containing the GATA motifs (proximal region, À138 to À37 bp) was amplified by qPCR. B) Amplification of a more distal Gata4 1b promoter fragment lacking GATA motifs (distal region, À3139 to À3002) was used as a secondary control. In both instances, ChIP using the GATA4 antibody detected a significant recruitment to the proximal Gata4 1b promoter when compared to the IgG control or in comparison to amplification on an unrelated distal promoter region. The results shown represent data from four independent experiments 6 SEM.
MAZAUD-GUITTOT ET AL.
WT GATA protein, FOG2 was much less effective at repressing GATA4 E215K-mediated activation the Gata4 1b promoter. Thus, these data suggest that the GATA4/FOG2 protein complex acts as a repressor of Gata4 1b promoter activity.
DISCUSSION
GATA4 protein plays a pivotal role in organogenesis and organ function. Despite its importance, we still know very little about the transcriptional mechanisms responsible for its expression. The GATA4 gene is expressed as multiple transcripts that differ in their first exon usage. The gonads express two predominant GATA4 transcripts: GATA4 E1a and GATA4 E1b. The proximally located Gata4 1a promoter, responsible for E1a transcript expression, is regulated by ubiquitous factors [45, 47, 48] . We report here the characterization of the newly identified distal Gata4 1b promoter. We defined the minimal region sufficient for maximal promoter activity and mapped two GATA-binding sites that control its basal promoter activity. GATA4 itself can bind to these GATA sites and interact with its cofactor FOG2 to downregulate Gata4 1b promoter activity. The upregulation of Gata4 E1b transcripts observed in a Gata4-null gonad background supports this autoregulatory mechanism.
Gonads are composite organs in which different cell types express GATA4: Sertoli, Leydig, and peritubular cells in the testis and granulosa, and theca and luteal cells in the ovary [reviewed in 6, 7, 23] . In agreement with data reported in mouse organs [38] , our PCR analysis of alternative Gata4 E1 usage in gonadal cell lines revealed that each cell type expressed a similar set of Gata4 transcripts in both testis cells (MSC-1 and TM4 Sertoli cells, TM3 and MA-10 Leydig cells) and in ovarian cells (DC3 granulosa cells). So while the composite cell type setting of the testis and ovary raised the interesting possibility of alternative exon usage at the organ level, we found that all gonadal cell types use both E1a and E1b. In addition, we were able to show endogenous in situ expression of both E1a and E1b Gata4 transcripts in rat gonads during development in Sertoli and Leydig testicular cells and in ovarian pregranulosa cells. Thus taken together, our current results confirm, at least in the gonads, the absence of cell specificity of Gata4 alternative E1 usage.
While the GATA4 gene does not exhibit cell-specific expression of its alternative transcripts in the gonads, quantification of the E1a and E1b transcripts during mouse ontogeny nonetheless revealed a dynamic pattern of E1 usage [48] . After a predominance of E1a transcript in the fetal testis, the level of each transcript becomes similar in postnatal mouse testes. In contrast, comparable expression of both transcripts in fetal ovaries is followed by a predominance of E1a in postnatal mouse ovaries [48] . Interestingly, this dynamic pattern of Gata4 transcript expression at the whole tissue level was not reflected at the level of the activities of the Gata4 1a and 1b promoters. In all the gonadal cell lines tested, the Gata4 1a promoter was consistently and considerably more active than the 1b promoter. The comparative weakness of promoter 1b may simply be a reflection of the differential control of the two promoters. We describe here that the Gata4 1b promoter is normally repressed by the GATA4/FOG2 complex. This repression is not seen at the level of the Gata4 1a promoter and therefore may partly explain the higher activity of the 1a promoter in the gonadal cell lines. Another explanation may reside with effects at the level of chromatin structure. Differences in chromatin structure at the level of the endogenous Gata4 1a and 1b promoters invariably contribute to the observed differences in E1a and E1b transcripts in gonadal cells in situ. Chromatin structure is inevitably absent in transiently transfected plasmids, and this may contribute to the apparent general weakness of the Gata4 1b promoter in transient transfection assays. Our transfection data also failed to show differences in Gata4 1b promoter activity between homologous and heterologous cell lines. Much like the Gata4 1a promoter [45] , basal transcriptional activity of the 1b promoter may also be controlled by ubiquitously expressed factors. A lack of Gata4 1b specificity observed in cell lines, however, does not necessarily indicate that these same (50 ng). An expression plasmid encoding the mutated GATA4 protein (E215K) was used to demonstrate that the FOG2 repressive effect requires interaction with GATA4. Data are reported as fold activation over control (6 SEM) . Different letters indicate significant differences between means (P , 0.05).
GATA4 GENE AUTOREGULATION sequences would be unable to contribute to tissue-specific Gata4 expression in vivo. This was indeed the case for the Gata4 1a regulatory sequences, which showed little specificity in cell lines but exhibited tissue-and cell-specific expression in transgenic mice [45, 46] .
Whereas alternative E1 usage clearly contributes to tissue specificity in the case of the hematopoietic Gata1/2/3 subfamily genes [40] , alternative E1 usage for Gata4 could suggest that leader exons could hold another role, as proposed for the closely related Gata6 gene [33] . Interestingly, polysome-associated mRNA analysis showed that both E1a and E1b Gata4 transcripts at least contribute to protein synthesis [38] . These data thus raise the question of the biological function of this apparent redundant leader exon and associated promoter usage. We originally hypothesized that it could either contribute to a high protein level of expression or ensure a backup to guarantee sufficient expression of Gata4 in a given cell type where its presence is crucial for cell function. The negative autoregulatory control loop elicited by GATA4 that we describe here favors the latter hypothesis. This hypothesis would also require that alternative Gata4 transcript expression be independently regulated. In agreement with this, Gata4 1a and 1b transcripts are under the control of different promoters that are regulated by drastically different pathways. Indeed, we and others previously described the activity and regulation of the Gata4 1a promoter by ubiquitous or at least widely expressed factors such as SP1 and USF1/2 on highly conserved GC-and E-boxes, respectively [45, 47] . It has also been shown in P19CL6 cells, an embryonal carcinoma cell line that has the ability to differentiate into cardiomyocytes in response to dimethyl sulfoxide, that the conserved GC-boxes and E-box proximal to the transcription initiation site are essential for Gata4 gene expression [49] . Our most recent in vivo study has confirmed that the Ebox motif is a key regulatory element for expression of the Gata4 E1a transcript [48] . Unlike the Gata4 1a promoter, we presently show that Gata4 1b promoter activity is negatively regulated by GATA4 itself.
In addition to the well-known interaction between AP1 family members associating as heterodimers to regulate expression of target genes [59] , FOS and JUN have been described to interact, either directly or indirectly through a common adapter protein, with gonadal transcription factors such as SF1/NR5A1, C/EBPb, and GATA4 [57, 60] . Whereas the cooperation of GATA4 and AP1 members was positive in the context of the Star and ANP promoters [57, 60] , we observed no cooperation between GATA4 and either FOS or JUN at the level of the Gata4 1b promoter. Rather, cotransfection of GATA4 with both FOS and JUN reduced the activation by GATA4 itself. WT1 is known to be an important regulator during embryonic development, especially in the kidney and the gonads [61] . We have previously shown that the WT1 (ÀKTS) and WT1 ( þKTS) isoforms transcriptionally cooperate with GATA4 on the promoters of genes essential for gonadal development, such as SRY and AMH [55] . Surprisingly, a similar GATA4/WT1 transcriptional cooperation was not observed on the Gata4 1b promoter in fibroblast kidney CV-1 cells. It can be postulated from this that basal Gata4 1b promoter activity, at least in vitro, is not dependent on AP1 family members and WT1.
Autoregulated expression is a common mechanism used by GATA factors, either in the minimal promoter located upstream of the first alternative exons or within enhancer sequences [32, 36, 62, 63] . Functional GATA-binding sites located in enhancers 40 and 80 kb upstream of the Gata4 gene have already been described in vivo. Enhancer-directed expression of Gata4 in liver and pancreas, stomach, and duodenum of transgenic mice and EMSA assays showed that GATA4 itself could efficiently bind to these sites [41, 42] . We presently show that Gata4 autoregulation also occurs on the FIG. 9. Proposed mechanism for the regulation of Gata4 gene transcription. A) GATA4 protein is efficiently produced via translation of E1a transcripts that are generated via ubiquitous factors USF1 and USF2 binding at a crucial Ebox at the level of the Gata4 1a promoter. GATA4 negatively autoregulates Gata4 1b transcription by binding to its sites at the level of the 1b promoter and by interaction with FOG2. B) When GATA4 protein is low because of reduced transcription at the Gata4 1a promoter, negative feedback inhibition by the GATA4/FOG2 complex at the 1b promoter is relieved; GATA4 protein levels are then assured by transcription via the Gata4 1b promoter. minimal Gata4 1b promoter, but not on the Gata4 1a promoter. Indeed, a conserved GATA-binding site located 1 kb upstream of 1a promoter has been shown to be regulated by Gata6 but not Gata4 in cardiac cells [49] . We here confirm the absence of Gata4 autoregulation on this GATA motif in gonadal cells. In contrast, transient expressed GATA4 could efficiently regulate its own expression by binding to conserved GATA motifs located upstream of E1b.
During embryonic development, autoregulation of transcription factors is a recognized mechanism contributing to cell fate determination and lineage commitment. For example, by positively regulating its own expression in T cell lymphocytes, Gata3 creates a feedback pathway stabilizing its pattern of expression and consequently cell commitment [64] . As well, two GATA sites flanking a CCAAC box located approximately 500 bp upstream of the erythroid-specific GATA1 transcription start site are involved in positive autoregulation of Gata1 transcription [63, 65, 66] . During testis development, such a mechanism has been described for Sox9 that binds a À13 kb regulatory region, consequently contributing to the maintenance of its own expression after SRY's initial stimulation of expression at this site [67] . It is then not surprising that the Gata4 gene is also autoregulated. In addition, reciprocal interactions creating intricate networks of regulations and checkpoints for gene expression have been documented for GATA factors. For instance, GATA2 autostimulates its own expression but can be displaced by GATA1, which directly represses Gata2 expression [68] [69] [70] . During gonad development, SOX8 is involved in the regulation of Sox9 expression [71] . This complex network may well also exist at the Gata4 locus because the conserved GATA-binding site located 1 kb upstream of 1a promoter was shown to be regulated by GATA6 in cardiac cells [49] , but not by GATA4.
GATA factors display either positive or negative regulation of target gene transcription. The activity of GATA proteins is also modulated by interacting with FOG cofactors [72] . In this study, we propose a model in which Gata4 senses its own expression to ensure GATA4 protein synthesis and maintenance of critical GATA4-dependent functions (Fig. 9) . Our initial in vitro results in heterologous cells suggested that Gata4 may well upregulate its own expression at the level of its 1b promoter. However, two lines of in vivo data indicate that GATA4 in association with FOG2 represses 1b promotermediated transcription. First, downregulation of Gata4 transcript synthesis from E1a by mutation of its crucial Ebox is associated with upregulation of Gata4 E1b-containing transcripts and maintenance of GATA4 protein levels and sites of expression [48] . Second, analysis of Gata4 E1a and E1b expression in embryos of mice with a conditional deletion of Gata4 in the gonads shows a significant upregulation of E1b transcripts compared to the WT tissues. These in vivo data therefore suggest that in a normal situation, transcription from the 1a promoter is sufficiently strong to furnish Gata4 transcripts and abundant GATA4 protein; in this context, 1b promoter activity is diminished by GATA4/FOG2-mediated repression (Fig. 9A) . However, in contexts where 1a promoter efficiency decreases or when GATA4 protein levels may be near a critical threshold such as in the early developing genital ridge [73] , Gata4 1b promoter activity may be upregulated to ensure that sufficient Gata4 transcripts are made for adequate GATA4 protein synthesis and function (Fig. 9B) .
